GENOMETX
DEAD

Serial Number

79406151

Owner

Genome Therapeutics Ltd

Filing Date

Aug 8, 2024

Add to watchlist:

No watchlists yet
View on USPTO

GENOMETX Trademark

Serial Number: 79406151

GENOMETX is a trademark filed by Genome Therapeutics Ltd on August 8, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Genome Therapeutics Ltd

Regent House,

Entity Type: 99

Trademark Details

Filing Date

August 8, 2024

Registration Date

Not Registered

Goods & Services

Chemical preparations and substances for use as pharmaceutical intermediates; chemical products for use in manufacturing pharmaceuticals.

Pharmaceutical and medicinal preparations and substances; chemical preparations for medical use.

Pharmaceutical research services; biomedical and biotechnological research and development services; chemical research services; development of pharmaceutical preparations and medicines; laboratory research and analysis services; laboratory testing services; medical laboratory services.

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 9, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 9, 2026 OPNR
NEW REPRESENTATIVE AT IB RECEIVED
Dec 18, 2025 NREP
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Oct 10, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 10, 2025 ABN2
REFUSAL PROCESSED BY IB
Apr 19, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 28, 2025 RFCS
REFUSAL PROCESSED BY MPU
Mar 28, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 22, 2025 RFCR
NON-FINAL ACTION WRITTEN
Feb 21, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 13, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 11, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 10, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 10, 2024 REPR